Clostridium Difficile

“Prevention is Better than a Cure”
This comment came to mind as I thought about why we vaccinate to prevent disease. Smallpox has been eliminated from the planet and we are very near doing the same with polio. In my memory, this was a frightening disorder to contract and thankfully the vaccine has eliminated polio from the USA.

Almost 1% of the people hospitalized in the United States will contract Clostridia Difficile colitis. Its prevalence in the hospital rivals that of ...

Continue Reading →

Three Year Metrics (2008 – 2010): Phase II – IV

Clinical Research Atlanta maintains performance metrics on a quarterly basis. In addition to metrics by therapeutic area, CRA is proud of some additional performance measures outlined below.

  • Regulatory and Contract Turnaround:  Less than one week
  • First Subject In from Contract Date:  1-2 days
  • eCRF data entry:  within 24 hours of patient visit and same day for queries generated by monitor visit.



(Includes Seasonal and Perennial Allergic Rhinitis, Asthma, COPD and Cold/Flu)

  • Number of Trials: 35
  • Screened Patients that Randomize: 74%
  • Contracted Enrollment that Complete Trial: 104%
  • Randomized ...
Continue Reading →

We Can’t do it Without You

What is a clinical trial?
Simply put, a clinical trial is the testing done on a new drug, medical device or procedure.
At CRA we conduct clinical drug trials for the pharmaceutical industry. Many of our trials are for vaccines.

Remember your flu shot?  It was tested for safety and effectiveness before it was made available to the public. We also conduct trials for conditions like hypertension, asthma, allergies, obesity, heartburn and many more.


Why do a clinical trial?
First, it helps get ...

Continue Reading →